Research graph
References from Management of Capillary Malformations. Local targets link to admitted publications; unresolved targets remain external evidence.
ISSVA vascular anomalies classification group. Updated classification of vascular anomalies. A living document from the international society for the study of vascular anomalies classification group
2025 · External reference
Nevus simplex: a reconsideration of nomenclature, sites of involvement, and disease associations
10.1016/j.jaad.2009.08.066 · 2010 · External reference
The misnomer “Macrocephaly-cutis marmorata telangiectatica congenita syndrome”: report of 12 new cases and support for revising the name to macrocephalycapillary malformations
10.1001/archdermatol.2008.545 · 2009 · External reference
Pyogenic granuloma (lobular capillary hemangioma) within port-wine stains
10.1016/s0190-9622(83)70068-x · 1983 · External reference
Impetiginized eczema arising within a port-wine stain of the arm
10.1111/j.1468-3083.2006.01600.x · 2006 · External reference
Early localized morphea mimicking an acquired port-wine stain
10.1016/j.jaad.2009.10.017 · 2011 · External reference
Early features of progressive hemifacial atrophy-clinical and imaging findings
10.1001/jamadermatol.2020.2593 · 2020 · External reference
Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ
10.1056/nejmoa1213507 · 2013 · External reference
GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features
10.1111/ene.15452 · 2022 · External reference
New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk
10.1111/bjd.13203 · 2014 · External reference
Forehead location and large segmental pattern of facial port-wine stains predict risk of Sturge-Weber syndrome
10.1016/j.jaad.2020.05.017 · 2020 · External reference
A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain
10.1016/j.jaad.2014.11.009 · 2015 · External reference
Size of facial port-wine birthmark may predict neurologic outcome in Sturge-Weber syndrome
10.1016/j.jpeds.2017.05.053 · 2017 · External reference
Sturge-Weber syndrome: a review
10.1016/j.pediatrneurol.2003.12.015 · 2004 · External reference
Sturge-Weber syndrome and epilepsy: an argument for aggressive seizure management in these patients
10.1586/14737175.7.8.951 · 2007 · External reference
Periocular port wine stain: the great ormond street hospital experience
10.1016/j.ophtha.2011.04.022 · 2011 · External reference
Sturge-Weber syndrome and dermatomal facial port-wine stains: incidence, association with glaucoma, and pulsed tunable dye laser treatment effectiveness
10.1097/01.prs.0000304606.33897.71 · 2008 · External reference
Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome
10.1016/j.jaapos.2009.04.007 · 2009 · External reference
Sturge-Weber syndrome
10.1016/j.sder.2004.01.002 · 2004 · External reference
Choroidal hemangioma
10.1016/j.ohc.2004.07.004 · 2005 · External reference
Consensus statement for the management and treatment of Sturge-Weber syndrome: neurology, neuroimaging, and ophthalmology recommendations
10.1016/j.pediatrneurol.2021.04.013 · 2021 · External reference
Epilepsy surgery in patients with Sturge-Weber syndrome
10.1016/j.yebeh.2025.110312 · 2025 · External reference
Redarkening of port-wine stains 10 years after laser treatment
10.1056/nejmc071123 · 2007 · External reference
Sturge-Weber syndrome: soft-tissue and skeletal overgrowth
10.1097/scs.0b013e318192988e · 2009 · External reference
Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP
10.1002/ajmg.c.31361 · 2013 · External reference
Microcephaly-capillary malformation syndrome
2013 · External reference
RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation
10.1002/humu.22431 · 2013 · External reference
Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling
10.1161/circulationaha.116.026886 · 2017 · External reference
Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS)
10.1111/exd.12826 · 2016 · External reference
Klippel-Trénaunay syndrome: spectrum and management
10.1016/s0025-6196(11)63615-x · 1998 · External reference
Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy
10.1016/j.jaad.2013.05.030 · 2013 · External reference
A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth
10.1007/s10456-016-9538-1 · 2017 · External reference
Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants
10.1111/cge.13702 · 2020 · External reference
A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowth
10.1016/j.jaad.2017.11.044 · 2018 · External reference
Cutis marmorata telangiectatica congenita: incidence of extracutaneous manifestations and a proposed clinical definition
10.1111/pde.15377 · 2023 · External reference
Limb length discrepancy in cutis marmorata telangiectatica congenita: an audit of assessment and management in a multidisciplinary setting
10.1111/bjd.12700 · 2014 · External reference
Effect of the timing of treatment of port-wine stains with the flash-lamp-pumped pulsed-dye laser
10.1056/nejm199804093381504 · 1998 · External reference
Consensus statement for the management and treatment of port-wine birthmarks in Sturge-Weber syndrome
10.1001/jamadermatol.2020.4226 · 2021 · External reference
Potential psychological benefits from early treatment of port-wine stains in children
10.1046/j.1365-2133.1998.02314.x · 1998 · External reference
Treatment of port-wine stains during childhood with the flashlamp-pumped pulsed dye laser
10.1016/0190-9622(90)70348-l · 1990 · External reference
Description and analysis of treatments for port-wine stain birthmarks
10.1001/archfaci.7.5.287 · 2005 · External reference
Herpes simplex infection and colonization with Pseudomonas aeruginosa complicating pulsed-dye laser treatment
2004 · External reference
Local molluscum contagiosum infection as a side-effect of pulsed-dye laser treatment
10.1111/j.1365-2133.2004.05964.x · 2004 · External reference
Development of extensive flat warts after pulsed dye laser treatment of a portwine stain
2007 · External reference
Treatment of pulsed dye laser-resistant port wine stain birthmarks
10.1016/j.jaad.2007.01.019 · 2007 · External reference
Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser
10.1001/archderm.1993.01680230066007 · 1993 · External reference
Prognosis and response to laser treatment of early-onset hypertrophic port-wine stains (PWS)
10.1016/j.jaad.2016.02.1167 · 2016 · External reference
Laser and light-based treatments for port-wine birthmarks - a systematic review and network meta-analysis
2025 · External reference
Long-pulsed neodymium:yttrium-aluminum-garnet laser treatment for port-wine stains
10.1016/j.jaad.2004.10.876 · 2005 · External reference
Long-pulsed 1,064-nm high-energy dye laser improves resistant port wine stains: 20 report cases
10.1007/s10103-012-1098-z · 2012 · External reference
Longpulsed neodymium:yttrium-aluminum-garnet laser treatment for hypertrophic port-wine stains on the lips
10.1080/14764170802307940 · 2009 · External reference
Treatment of resistant port-wine stains with a pulsed dual wavelength 595 and 1064 nm laser: a histochemical evaluation of the vessel wall destruction and selectivity
10.1089/pho.2008.2356 · 2009 · External reference
Combined 595-nm and 1,064-nm laser irradiation of recalcitrant and hypertrophic portwine stains in children and adults
10.1111/j.1524-4725.2009.01155.x · 2009 · External reference
Fractional thermoablation using an erbium-doped yttrium aluminum garnet fractionated laser for the treatment of pulsed dye laser-resistant port wine stain birthmarks
10.1111/j.1524-4725.2011.02160.x · 2011 · External reference
Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients
10.1002/lsm.20793 · 2009 · External reference
Treatment endpoints for resistant port wine stains with a 755 nm laser
10.1080/14764170802524452 · 2009 · External reference
Treatment of port wine stains with intense pulsed light: a prospective study
2004 · External reference
Treatment of facial port-wine stains with intense pulsed light: a prospective study
10.1111/j.1473-2165.2008.00375.x · 2008 · External reference
Intense pulsed light source for the treatment of dye laser resistant port-wine stains
2003 · External reference
Pulsed dye laser vs. intense pulsed light for port-wine stains: a randomized side-by-side trial with blinded response evaluation
10.1111/j.1365-2133.2008.08993.x · 2009 · External reference
Hemoporfin photodynamic therapy for port-wine stain: a randomized controlled trial
10.1371/journal.pone.0156219 · 2016 · External reference
Efficacy of photodynamic therapy in the treatment of port wine stains: a systematic review and meta-analysis
2023 · External reference
Treatment of port wine stains with photodynamic therapy, using pulsed dye laser as a light source, compared with pulsed dye laser alone: a pilot study
10.1002/lsm.20151 · 2005 · External reference
Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial
10.1111/bjd.12772 · 2014 · External reference
Pilot study examining the combined use of pulsed dye laser and topical imiquimod versus laser alone for treatment of port wine stain birthmarks
10.1002/lsm.20716 · 2008 · External reference
Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial
10.1016/j.jaad.2014.10.011 · 2015 · External reference
Delayed ulceration following combination pulse dye laser and topical sirolimus treatment for port wine birthmarks: a case series
10.1111/pde.15409 · 2024 · External reference
The pathogenesis of port wine stain and Sturge Weber syndrome: complex interactions between genetic alterations and aberrant MAPK and PI3K activation
10.3390/ijms20092243 · 2019 · External reference
MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ
10.1038/s41467-023-37516-7 · 2023 · External reference
